FAQ/Help |
Calendar |
Search |
Today's Posts |
03-07-2017, 09:38 PM | #1 | ||
|
|||
Member
|
Researchers from the University of South Florida found in a retrospective analysis of clinical trial data that long-term use of monoamine oxidase type B, or MAO-B, inhibitors slows the clinical decline of patients with Parkinson's disease.
Parkinson's decline slowed with extended MAO-B inhibitors - UPI.com |
||
Reply With Quote |
"Thanks for this!" says: |
|
|
Similar Threads | ||||
Thread | Forum | |||
Parkinson's Disease Cure Update: Diabetes Drug That May Slow Progression Is Being Rea | Parkinson's News | |||
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compa | Parkinson's Disease | |||
New Parkinson's Drug Could Slow Disease Progression | Parkinson's Disease |